Lindbrook Capital, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$11,527
+10.3%
429
+46.4%
0.00%0.0%
Q2 2023$10,448
+112.0%
293
+51.0%
0.00%0.0%
Q1 2023$4,928
-81.8%
194
-71.0%
0.00%
-66.7%
Q4 2022$27,094
+12.9%
668
-8.0%
0.00%
-25.0%
Q3 2022$24,000
-4.0%
726
+1.0%
0.00%0.0%
Q2 2022$25,000
-24.2%
719
+0.1%
0.00%
-20.0%
Q1 2022$33,000
-56.6%
718
-37.2%
0.01%
-58.3%
Q4 2021$76,000
+7500.0%
1,144
+10300.0%
0.01%
Q3 2021$1,000
-92.9%
11
-94.8%
0.00%
-100.0%
Q1 2021$14,000
-67.4%
213
-78.7%
0.00%
-75.0%
Q3 2020$43,0001,0000.01%
Q2 2020$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2019$33,000
-21.4%
515
-65.7%
0.01%
-31.2%
Q3 2019$42,000
+7.7%
1,5000.0%0.02%
+6.7%
Q2 2019$39,000
-46.6%
1,500
-62.5%
0.02%
-48.3%
Q1 2019$73,000
+40.4%
4,000
-4.8%
0.03%
+11.5%
Q4 2018$52,0004,2000.03%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders